These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2567038)
21. 5-HT(3) receptor antagonists and anxiety; a preclinical and clinical review. Olivier B; van Wijngaarden I; Soudijn W Eur Neuropsychopharmacol; 2000 Mar; 10(2):77-95. PubMed ID: 10706989 [TBL] [Abstract][Full Text] [Related]
22. Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors. Sánchez-Lopez A; Centurión D; Vázquez E; Arulmani U; Saxena PR; Villalón CM Br J Pharmacol; 2003 Oct; 140(4):725-35. PubMed ID: 14504136 [TBL] [Abstract][Full Text] [Related]
23. The effects of AP521, a novel anxiolytic drug, in three anxiety models and on serotonergic neural transmission in rats. Kasahara K; Hashimoto S; Hattori T; Kawasaki K; Tsujita R; Nakazono O; Takao K; Kawakubo H; Nagatani T J Pharmacol Sci; 2015 Jan; 127(1):109-16. PubMed ID: 25704026 [TBL] [Abstract][Full Text] [Related]
24. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists. Prosser RA; Dean RR; Edgar DM; Heller HC; Miller JD J Biol Rhythms; 1993; 8(1):1-16. PubMed ID: 8490207 [TBL] [Abstract][Full Text] [Related]
29. Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models. Gupta D; Radhakrishnan M; Thangaraj D; Kurhe Y Eur J Pharmacol; 2014 Jul; 735():59-67. PubMed ID: 24747753 [TBL] [Abstract][Full Text] [Related]
30. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors. Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650 [TBL] [Abstract][Full Text] [Related]
31. 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype. Schoeffter P; Hoyer D J Pharmacol Exp Ther; 1990 Jan; 252(1):387-95. PubMed ID: 2137176 [TBL] [Abstract][Full Text] [Related]
32. Recent developments in 5HT-related pharmacology of animal models of anxiety. Gardner CR Pharmacol Biochem Behav; 1986 May; 24(5):1479-85. PubMed ID: 2873594 [TBL] [Abstract][Full Text] [Related]
33. Serotonergic neurons in the median raphe nucleus regulate inhibitory avoidance but not escape behavior in the rat elevated T-maze test of anxiety. Dos Santos L; de Andrade TG; Zangrossi H Psychopharmacology (Berl); 2005 Jun; 179(4):733-41. PubMed ID: 15619105 [TBL] [Abstract][Full Text] [Related]
34. The role of serotonin in depression and anxiety. Baldwin D; Rudge S Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():41-5. PubMed ID: 7622823 [TBL] [Abstract][Full Text] [Related]
35. 5-HT-1A receptor responsiveness following subchronic administration of buspirone. Khan A; Haleem DJ Pak J Pharm Sci; 2006 Oct; 19(4):333-7. PubMed ID: 17105715 [TBL] [Abstract][Full Text] [Related]